BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17689341)

  • 1. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.
    Rhodes T; Watts L; Davies S; Martin A; Smith J; Clark D; Craine N; Lyons M
    Soc Sci Med; 2007 Aug; 65(3):572-85. PubMed ID: 17475383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.
    Kerr T; Wood E; Small D; Palepu A; Tyndall MW
    CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter Olympics.
    Small W; Krusi A; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2012 Mar; 23(2):128-33. PubMed ID: 21885271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorescent blue lights, injecting drug use and related health risk in public conveniences: findings from a qualitative study of micro-injecting environments.
    Parkin S; Coomber R
    Health Place; 2010 Jul; 16(4):629-37. PubMed ID: 20167527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
    Fairbairn N; Small W; Shannon K; Wood E; Kerr T
    Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with public injecting among users of Vancouver's supervised injection facility.
    McKnight I; Maas B; Wood E; Tyndall MW; Small W; Lai C; Montaner JS; Kerr T
    Am J Drug Alcohol Abuse; 2007; 33(2):319-25. PubMed ID: 17497555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): a Lefebvrian analysis.
    Parkin S; Coomber R
    Health Place; 2011 May; 17(3):717-26. PubMed ID: 21440483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm.
    Rhodes T; Kimber J; Small W; Fitzgerald J; Kerr T; Hickman M; Holloway G
    Addiction; 2006 Oct; 101(10):1384-93. PubMed ID: 16968336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower injection-related HIV-1 risk associated with participation in a harm reduction program in Kazan, Russia.
    Badrieva L; Karchevsky E; Irwin KS; Heimer R
    AIDS Educ Prev; 2007 Feb; 19(1):13-23. PubMed ID: 17411386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Route transition interventions: potential public health gains from reducing or preventing injecting.
    Bridge J
    Int J Drug Policy; 2010 Mar; 21(2):125-8. PubMed ID: 20167464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.